Multiplex ligation-dependent probe amplification of uveal melanoma: Correlation with metastatic death

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3048-3055

  Damato, Bertil ^a   Dopierala, Justyna ^b   Klaasen, Annelies ^c   van Dijk, Marcory ^d   Sibbring, Julie ^e   Coupland, Sarah E ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BINDING PROTEIN; COPROPORPHYRINOGEN OXIDASE; DNA; DNA GLYCOSYLASE MUTY; ELONGATION FACTOR 1; FANCONI ANEMIA GROUP D2 PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; GENE PRODUCT; MEMBRANE METALLOENDOPEPTIDASE; MITOFUSIN 2; MYC BINDING PROTEIN; NEU DIFFERENTIATION FACTOR; NOTCH2 RECEPTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN MUTL; RETINA PIGMENT EPITHELIUM SPECIFIC PROTEIN 65; RETINITIS PIGMENTOSA 1 PROTEIN; RHODOPSIN; ROUNDABOUT RECEPTOR; SEMAPHORIN; SEMAPHORIN 3B; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN B RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXC1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME LOSS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PARTIAL HEPATECTOMY; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR VOLUME; UVEA MELANOMA; CHROMOSOME 1; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8; DNA PROBE; GENETICS; LIVER TUMOR; MELANOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; POLYMERASE CHAIN REACTION; SURVIVAL RATE; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DNA PROBES; DNA, NEOPLASM; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 67649961694     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3165     Document Type: Article

References (23)

1. Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003; 44:4651-4659.
2. McLean IW, Foster WD, Zimmerman LE, et al. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96:502-509.
3. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115:1778-1785.
4. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298-1305.
5. Kivelä T, Mäkitie T, Al-Jamal RT, et al. Microvascular loops and networks in uveal melanoma. Can J Ophthalmol. 2004;39:409-421.
6. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222-1225.
7. White VA, Chambers JD, Courtright PD, et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83:354-359.
8. Aalto Y, Eriksson L, Seregard S, et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:313-317.
9. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res. 1999;59:3032-3037.
10. Kilic E, Naus NC, van Giles W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46:2253-2257.
11. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a seven-year clinical experience. Ophthalmology. 2007;114:1925-1931.
12. Tschentscher F, Prescher G, Horsman DE, et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res. 2001;61:3439-3442.
13. Parrella P, Fazio VM, Gallo AP, Sidransky D, Merbs SL. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res. 2003;63:8507-8510.
14. Damato B, Eleuteri A, Fisher AC, et al. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology. 2008;115:1598-1607.
15. van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol. 2005;14:9-16.
16. Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44:1008-1011.
17. Young TA, Burgess BL, Rao NP, et al. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Mol Vis. 2007;13:2328-2333.
18. Mensink HW, Kilic E, Vaarwater J, et al. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet. 2008;181:108-111.
19. Takata M, Suzuki T, Ansai S, et al. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): its usefulness as an adjunctive diagnostic tool for melanocytic tumors. J Dermatol Sci. 2005;40:51-57.
20. White VA, McNeil BK, Thiberville L, et al. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity. Genes Chromosomes Cancer. 1996;15:138-143.
21. Sandinha T, Farquharson M, McKay I, et al. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Invest Ophthalmol Vis Sci. 2006;47:5177-5180.
22. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med. 2007;131:91-96.
23. Ehlers JP, Worley L, Onken MD, et al. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res. 2008;14:115-122.